About BiondVax Pharmaceuticals Ltd. (BVXV) — Dividend Analysis 2026
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.
Is BVXV a good dividend investment in 2026?
BVXV offers a 147.06% forward yield with a 50% payout ratio. Strand Safety Score: 15/100 (Critical Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
BVXV DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your BVXV portfolio grows to $84.72M vs $157.1K without reinvestment. This is the compound interest effect in action.
BVXV dividend growth history & forecast
BVXV has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 147.06%.
Company generates negative FCF ($-8M) — borrowing to pay dividends
Debt Leverage0.0× Debt/EBITDA
0 / 30 pts
0/30
Company not generating EBITDA — debt servicing risk is elevated
Earnings Momentum-0.0B → -0.1B → +0.0B
15 / 30 pts
15/30
Net income grew in the latest year — positive but trend is unconfirmed
OVERALL ASSESSMENT
High risk of dividend cut — weak fundamentals across multiple factors.
STRAND SCORE
15
/100
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 BVXV Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold BVXV.
Gross yield
147.06%
Tax rate
15.00%
After-tax yield
125.00%
Real yield (−CPI)
122.20%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
147.06%
144.26%
$14,706 / yr
🇺🇸 US Taxable (15%) ✓
15%
125.00%
122.20%
$12,500 / yr
🇺🇸 US Taxable (20%)
20%
117.65%
114.85%
$11,765 / yr
🇬🇧 UK ISA
0%
147.06%
144.26%
$14,706 / yr
🇬🇧 UK Taxable
8.75%
134.19%
131.39%
$13,419 / yr
🇨🇦 TFSA
0%
147.06%
144.26%
$14,706 / yr
🇨🇦 CA Taxable
25%
110.30%
107.50%
$11,030 / yr
🇦🇺 Super (pension)
15%
125.00%
122.20%
$12,500 / yr
🇦🇺 AU Taxable
30%
102.94%
100.14%
$10,294 / yr
🇩🇪 DE Taxable
26.375%
108.27%
105.47%
$10,827 / yr
🇫🇷 FR Taxable
30%
102.94%
100.14%
$10,294 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 BVXV Income Goal & Break-Even
Dividend Break-Even
1yr
Years for dividends to fully repay your BVXV investment of $1.36/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$33.24M
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$33.24M
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in BVXV for:
Shares needed
14,118
Capital required
$19,200
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 BVXV Dividend Payment Schedule
BVXV pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 BVXV vs Healthcare Benchmarks
How BVXV compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+144.26% vs sectorBetter
BVXV
147.06%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
BVXV
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
BVXV
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BVXV sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ BVXV Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
Insider
Title
Type
Date
Shares
Price
Total Value
MARGOLIN YAEL
director
Other
2023-01-01
133,200
—
—
Laster Morris C
director
Other
2023-01-01
133,200
—
—
Lowell George
director
Other
2023-01-01
133,200
—
—
Rotman Avner
director
Other
2023-01-01
133,200
—
—
Moed Samuel J
director
Other
2023-01-01
3,280,000
$0.17
$570.7K
Green Jay
director
Other
2023-01-01
1,000,000
$0.07
$73.0K
MARGOLIN YAEL
director
Other
2023-01-01
133,200
—
—
Ben-Or Uri
officer: Chief Financial Officer
Other
2024-10-18
830,000
—
—
Ben-Yedidia Tamar
officer: Chief Scientist
Other
2025-03-23
1,500,000
—
—
Laster Morris C
director
Other
2023-01-01
1,000,000
$1.74
$1.74M
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
🔬
Financial Health Scores
Altman Z-Score
-8.43
🔴 Distress Zone — elevated dividend cut risk
Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81
Piotroski F-Score
4/9
⚠️ Moderate fundamentals
Strong: 7–9 · Moderate: 4–6 · Weak: 0–3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BVXV dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →